Return
Company Page
Septest
Founders
Septest is a UK-based medical diagnostics startup developing TRISEP, a rapid point-of-care test designed to detect infection and monitor inflammatory response across conditions including sepsis, pneumonia, tuberculosis, COVID, and autoimmune disease. Founded from a personal experience with sepsis, the company aims to empower frontline clinicians with faster, clearer diagnostic insight to improve patient outcomes and support antimicrobial stewardship.
Company Founded in 2022
Healthtech & Biotech